MedPath

A study on the effect of gastric bypass on the absortpion of metoprolol immediate release tablet.

Conditions
Roux- en-Y gastric bypass
<br />Metoprolol<br />immediate release tabletabsorptiongastric bypassmetoprololdirecte afgifte tabletabsorptie
Registration Number
NL-OMON29306
Lead Sponsor
Medisch Centrum Leeuwarden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Female gender;

- Age 18-50 years;

Exclusion Criteria

- Pregnancy;

- Smoking;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Parameters that will be determined before and after surgery are Cmax, Tmax, and<br>AUC0-10 of metoprolol and its main active metabolite &#945;-OH metoprolol.<br><br>The main endpoint is the ratio of AUCafter/AUCbefore of metoprolol and &#945;-OH metoprolol.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoint is the quotient of the ratios of the AUC of metoprolol and its metabolite after and before.<br><br><br>Other study parameters<br>Blood pressure and heart rate measured at t = 0, 2, 4, 8 and 10 hours after intake of metoprolol.<br><br>Further analysis<br>After completion of the other pharmacokinetic study with metoprolol controlled release tablet relevant parameters may be compared for further analysis.
© Copyright 2025. All Rights Reserved by MedPath